Ibopamine eye drops in the treatment of hypotony after vitreoretinal surgery in retinal detachment or uveitis
| ISRCTN | ISRCTN36001452 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN36001452 |
| Secondary identifying numbers | OZR-2002-17; NTR187 |
- Submission date
- 20/12/2005
- Registration date
- 20/12/2005
- Last edited
- 04/11/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr J C van Meurs
Scientific
Scientific
Oogziekenhuis Rotterdam
Schiedamsevest 180
Rotterdam
3011 BH
Netherlands
| Phone | +31 (0)10 401 7777 |
|---|---|
| vanMeurs@oogziekenhuis.nl |
Study information
| Study design | Randomised, single blinded, placebo controlled, crossover trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Other |
| Study type | Treatment |
| Scientific title | |
| Study objectives | Administration of Ibopamine hydrochloride eye drops restores intraocular pressure in patients with hypotony following vitreoretinal surgery or uveitis. |
| Ethics approval(s) | Received from the local medical ethics committee |
| Health condition(s) or problem(s) studied | Ocular hypotony following either vitreoretinal surgery or uveitis |
| Intervention | Treatment with ibopamine hydrochloride (0.5 % or 2%) eye drops or placebo. |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | Ibopamine hydrochloride |
| Primary outcome measure | Ocular pressure on treatment day |
| Secondary outcome measures | No secondary outcome measures |
| Overall study start date | 01/01/2003 |
| Completion date | 01/04/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 15 (study completed) |
| Key inclusion criteria | 1. Hypotony (0 - 5 mmHg) 2. Stable eye pressure for at least 4 months 3. No reaction of eye pressure to atropine and steroids 4. Continued steroid treatment during past six months 5. Status after vitreoretinal surgery or uveitis |
| Key exclusion criteria | 1. Chronic heart failure 2. Traction on corpus ciliare 3. Cyclodialysis |
| Date of first enrolment | 01/01/2003 |
| Date of final enrolment | 01/04/2003 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
Oogziekenhuis Rotterdam
Rotterdam
3011 BH
Netherlands
3011 BH
Netherlands
Sponsor information
Rotterdam Eye Hospital (Oogziekenhuis Rotterdam) (The Netherlands)
Hospital/treatment centre
Hospital/treatment centre
Schiedamsevest 180
Rotterdam
3011 BH
Netherlands
| Phone | +31 (0)10 401 77 77 |
|---|---|
| info@oogziekenhuis.nl | |
"ROR" |
https://ror.org/02hjc7j46 |
Funders
Funder type
Hospital/treatment centre
Foundation of Scientific Research at the Eye Hospital (Stichting Wetenschappelijk Onderzoek het Oogziekenhuis) (The Netherlands)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results | 01/03/2006 | Yes | No |
